CTTQ
Status and phase
Conditions
Treatments
About
To study the single dose and multi-doses pharmacokinetic characteristics and tolerance of TQ-A3326 in the human body;To study the transformation of TQ-A3326;To study the effect of the food on the pharmacokinetic characteristics of TQ-A3326.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Li Xin, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal